US Drug Recall Register
Class II · Moderate risk Terminated Initiated Sep 19, 2011 (15 years ago)

Arthrotec 75

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Tablet Separation: The manufacturer of Arthrotec had recalled the lots that were used to re-package this product because they may contain broken tablets.

What was recalled

Arthrotec 75 (diclofenac sodium and misoprostol) tablets, 75 mg/200 mcg, a) 30-count tablets per bottle (NDC 54868-4165-1); b) 60-count tablets per bottle (NDC 54868-4165-0); Rx only, Mfg. By: G.D. searle LLC Div Pfizer, New York, NY 10017; Repacked & distributed by: Physicians total Care, Inc., Tulsa, OK 74146.

Recalling firm
Physicians Total Care, Inc.
NDC code
54868-4165-1
Origin
OK, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1379-2012

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Diclofenac recalls

See all
Class II · Moderate risk Ongoing

Diclofenac Sodium

Reason Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.

Sun Pharmaceutical Industries INC NDC 51672-1363-7 D-0342-2026
Class II · Moderate risk Terminated

Diclofenac Sodium Topical Solution 1.5% w/w

Reason CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.

Preferred Pharmaceuticals, Inc. NDC 68788-7918-01 D-0773-2022
Class II · Moderate risk Terminated

Diclofenac Sodium Topical Solution USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 70512-025-05 D-0680-2022